• Study on Giredestrant and Everolimus for Patients with Estrogen Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Germany Greece Italy Spain

  • Study on the Safety of DNL310 for Children with Hunter Syndrome

    Not recruiting

    2 1 1
    Investigated diseases:
    The Netherlands

  • Study of Durvalumab, Tremelimumab, and Bevacizumab for Patients with Non-Resectable Liver Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Germany Italy

  • Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

    Not recruiting

    3 1 1
    Investigated diseases:
    Belgium Czechia France Germany Greece Hungary +3

  • Study of BAN2401 (lecanemab) in people with early stage Alzheimer’s disease to evaluate its effectiveness in preventing disease progression

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Spain

  • Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Czechia France Italy Poland +2

  • Study comparing stem cell transplantation versus alemtuzumab, cladribine or ocrelizumab in patients with aggressive relapsing-remitting multiple sclerosis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Denmark The Netherlands Norway Sweden

  • Study on the Safety and Effectiveness of Bezuclastinib for Patients with Advanced Systemic Mastocytosis

    Not recruiting

    2 1 1
    Investigated diseases:
    Austria Belgium France Germany Italy The Netherlands +3

  • Study on Eye Health During Treatment with Mirvetuximab Soravtansine, Brimonidine Tartrate, and Prednisolone Acetate for Patients with Recurrent Ovarian Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Belgium France Ireland Spain

  • Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    3 1
    Investigated diseases:
    Bulgaria Czechia Hungary Poland Romania

powered by